These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 23176145

  • 21. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.
    Zheng B, Liang L, Huang S, Zha R, Liu L, Jia D, Tian Q, Wang Q, Wang C, Long Z, Zhou Y, Cao X, Du C, Shi Y, He X.
    Oncogene; 2012 Oct 18; 31(42):4509-16. PubMed ID: 22179828
    [Abstract] [Full Text] [Related]

  • 22. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.
    Namwat N, Puetkasichonpasutha J, Loilome W, Yongvanit P, Techasen A, Puapairoj A, Sripa B, Tassaneeyakul W, Khuntikeo N, Wongkham S.
    J Gastroenterol; 2011 May 18; 46(5):664-75. PubMed ID: 21076843
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-21 is involved in osteosarcoma cell invasion and migration.
    Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L.
    Med Oncol; 2011 Dec 18; 28(4):1469-74. PubMed ID: 20480266
    [Abstract] [Full Text] [Related]

  • 24. MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer.
    Zhang C, Ge S, Hu C, Yang N, Zhang J.
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec 18; 45(12):1055-61. PubMed ID: 24247270
    [Abstract] [Full Text] [Related]

  • 25. RECK regulated endoplasmic reticulum stress response and enhanced cisplatin-induced cell death in neuroblastoma cells.
    Chen Y, Tsai YH, Tseng SH.
    Surgery; 2013 Nov 18; 154(5):968-79. PubMed ID: 24084596
    [Abstract] [Full Text] [Related]

  • 26. Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.
    Pramanik KK, Singh AK, Alam M, Kashyap T, Mishra P, Panda AK, Dey RK, Rana A, Nagini S, Mishra R.
    Tumour Biol; 2016 Nov 18; 37(11):15253-15264. PubMed ID: 27696293
    [Abstract] [Full Text] [Related]

  • 27. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
    Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada J, Miyamoto M, Kondo S, Moriuchi T.
    Lung Cancer; 2007 Dec 18; 58(3):376-83. PubMed ID: 17714826
    [Abstract] [Full Text] [Related]

  • 28. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS, Wang TH, Lai CH.
    Oncogene; 2012 Feb 09; 31(6):764-75. PubMed ID: 21725366
    [Abstract] [Full Text] [Related]

  • 29. MiR-21 overexpression improves osteoporosis by targeting RECK.
    Zhao W, Dong Y, Wu C, Ma Y, Jin Y, Ji Y.
    Mol Cell Biochem; 2015 Jul 09; 405(1-2):125-33. PubMed ID: 25893734
    [Abstract] [Full Text] [Related]

  • 30. Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines.
    Takagi S, Hoshino Y, Osaki T, Okumura M, Fuginaga T.
    Exp Oncol; 2007 Mar 09; 29(1):30-4. PubMed ID: 17431385
    [Abstract] [Full Text] [Related]

  • 31. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, Li G, Lu X, Sun Z, Tang KF.
    Carcinogenesis; 2012 Mar 09; 33(3):519-28. PubMed ID: 22198213
    [Abstract] [Full Text] [Related]

  • 32. Exosomal miR-182 regulates the effect of RECK on gallbladder cancer.
    Zheng H, Wang JJ, Zhao LJ, Yang XR, Yu YL.
    World J Gastroenterol; 2020 Mar 07; 26(9):933-946. PubMed ID: 32206004
    [Abstract] [Full Text] [Related]

  • 33. MicroRNA-15b regulates reversion-inducing cysteine-rich protein with Kazal motifs (RECK) expression in human uterine leiomyoma.
    Guan Y, Guo L, Zukerberg L, Rueda BR, Styer AK.
    Reprod Biol Endocrinol; 2016 Aug 17; 14(1):45. PubMed ID: 27530410
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lentivirus-mediated reversion-inducing cysteine-rich protein with Kazal motifs gene transfer suppresses pancreatic cancer invasion in vitro.
    Tian QS, Li DC.
    Saudi Med J; 2010 Jul 17; 31(7):752-8. PubMed ID: 20635007
    [Abstract] [Full Text] [Related]

  • 37. MiR-25 promotes gastric cancer cells growth and motility by targeting RECK.
    Zhao H, Wang Y, Yang L, Jiang R, Li W.
    Mol Cell Biochem; 2014 Jan 17; 385(1-2):207-13. PubMed ID: 24078004
    [Abstract] [Full Text] [Related]

  • 38. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
    Span PN, Sweep CG, Manders P, Beex LV, Leppert D, Lindberg RL.
    Cancer; 2003 Jun 01; 97(11):2710-5. PubMed ID: 12767082
    [Abstract] [Full Text] [Related]

  • 39. Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.
    Liu N, Cao Y, Zhu G.
    Arch Oral Biol; 2017 Mar 01; 75():62-67. PubMed ID: 28043014
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.
    Lei L, Huang Y, Gong W.
    Mol Cell Biochem; 2014 Feb 01; 387(1-2):171-6. PubMed ID: 24162673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.